Pitcairn’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,397
Closed -$510K 520
2014
Q4
$510K Sell
2,397
-231
-9% -$45.9K 0.05% 240
2014
Q3
$468K Hold
2,628
0.05% 269
2014
Q2
$445K Sell
2,628
-320
-11% -$49.8K 0.05% 267
2014
Q1
$365K Sell
2,948
-350
-11% -$42.6K 0.04% 326
2013
Q4
$367K Sell
3,298
-6,020
-65% -$575K 0.04% 336
2013
Q3
$843K Sell
9,318
-1,445
-13% -$130K 0.1% 158
2013
Q2
$907K Buy
+10,763
New +$1.12M 0.12% 161

Other funds holding AGN

Pitcairn's AGN Position: Q1 2015 in Review

Pitcairn sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,397 shares — an estimated $510K sold.

Pitcairn first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $907K in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Pitcairn reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Pitcairn sold 2,397 Allergan Inc shares in Q1 2015, an estimated $510K.
  • Pitcairn first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Pitcairn's Allergan Inc position peaked at $907K in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Pitcairn's 13F filing for Q1 2015, filed 14 May 2015.